Cancer · 1989 · 166 citations · 17 references
MedicineOncologySurgeryChemotherapyMedical OncologySurgical OncologyChemotherapy Drug AdministrationChemotherapy Toxicity ManagementCombination ChemotherapySupportive Care In CancerToxicity ManagementChemotherapy Dose IntensityDesmoid Tumor TherapyEastern Cooperative Oncology Group Performance StatusSymptomatic Therapy
Eight patients with desmoid tumors, symptomatic, and none a candidate for conservative surgery, were treated with weekly vinblastine, maximum dose 10 mg/week, and methotrexate, maximum dose 50 mg/week. Symptomatic relief was obtained in all patients. Using Eastern Cooperative Oncology Group (ECOG) criteria, two patients had a complete remission, one of which has lasted for 30 months, four patients have had partial remissions, one patient has had a mixed response, and one patient who has been treated for only 4 weeks, a minimal response. Toxicity has been minor and transient. Chemotherapy appears to be an acceptable alternative to radical surgery in selected patients with desmoid tumors.
17
Cancer: Principles and Practice of Oncology.
Annals of Internal Medicine · 1991 · 8.5K citations
Medicine, Oncology, Oncology Nursing +10
Cancer: Principles and Practice of Oncology.
Annals of Internal Medicine · 1986 · 1.1K citations
Medicine, Oncology, Oncology Nursing +10
Jyrki J. Reitamo, Teddy M. Schelnin, P Häyry · The American Journal of Surgery · 1986 · 466 citations
Mitchell C. Posner · Archives of Surgery · 1989 · 329 citations
Extra-abdominal desmoid tumors.
Michael G. Rock, D J Pritchard, H.M. Reiman et al. · Journal of Bone and Joint Surgery · 1984 · 315 citations